Clinical Trial Update: Clinical Study of Umbilical Cord Tissue Mesenchymal Stem Cells (UC-MSC) for Treatment of Osteoarthritis [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating umbilical cord tissue-derived mesenchymal stem cells for osteoarthritis of the knee has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis of the Knee

Drugs mentioned

• UC-MSC (umbilical cord tissue-derived mesenchymal stem cells) (umbilical cord tissue mesenchymal stem cells)

Snippet

Sponsor: Translational Biosciences | Conditions: Osteoarthritis of the Knee | Phase 1, Phase 2 | Status: WITHDRAWN